BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$281.97 USD
+2.14 (0.76%)
Updated May 6, 2024 04:00 PM ET
After-Market: $281.64 -0.33 (-0.12%) 6:00 PM ET
4-Sell of 5 4
D Value D Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Bio-Rad Laboratories, Inc. [BIO]
Reports for Purchase
Showing records 101 - 120 ( 140 total )
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Bio-Rad Laboratories, Inc.
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department